Diagnostic yields and clinical impact of endoscopic ultrasound‐guided tissue acquisition for biliary lesions
Journal of Hepato-Biliary-Pancreatic Sciences · 2025
DOI: 10.1002/jhbp.12143 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Hepato-Biliary-Pancreatic Sciences, 2025. Verfasst von Daiki Agarie und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan. Hauptthemen laut MEDLINE: Endosonography, Endoscopic Ultrasound-Guided Fine Needle Aspiration. Die Arbeit nennt 30 Literaturangaben. Gefördert von: National Cancer Center Japan.
Abstract (Originalsprache)
Background/Purpose Diagnostic yields of endoscopic ultrasound‐guided tissue acquisition (EUS‐TA) for biliary lesions have not been fully established due to limited evidence. We aimed to clarify the efficacy of EUS‐TA for biliary lesions.
Methods
Diagnostic yields and adverse event rates of EUS‐TA for biliary lesions were evaluated. The subject cases were only limited to cases in which the biliary lesions itself was punctured. Diagnostic yields of endoscopic retrograde cholangiography (ERC)‐guided biopsy/cytology performed within the same period were also evaluated to assess the additional effect of EUS‐TA.
Results
EUS‐TA was attempted in 71 cases (28 hilar bile duct, 19 distal bile duct, 4 ampulla of Vater, and 20 gallbladder), and the final diagnosis was malignant in 54 cases (76.1%). The sensitivity, specificity, and accuracy of EUS‐TA were 96.3% (52/54), 100% (17/17), and 97.2% (69/71), respectively. Adverse events were observed in one case (1.4%, peritonitis). The accuracy of ERC biopsy/cytology was 82.5% (212/257 cases); additional EUS‐TA diagnosed 30 cases as malignant additionally and improved the accuracy (94.2%; 242/257 cases; p < .01).
Conclusions
EUS‐TA is an accurate and safe diagnostic test for biliary lesions. The addition of EUS‐TA may be considered when there is a suspicion of a false‐negative ERC result.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan.
- Division of Infectious, Respiratory, and Digestive Medicine, First Department of Internal Medicine, University of the Ryukyus, Okinawa, Japan.
ORCID-Profile: Daiki Agarie, Susumu Hijioka, Kohei Okamoto
Förderung
- National Cancer Center Japan
Zitieren
APA
Agarie, D., Hijioka, S., Nagashio, Y., Yamashige, D., Okamoto, K., Yagi, S., Fukuda, S., Harai, S., Yamamoto, K., & Okusaka, T. (2025). Diagnostic yields and clinical impact of endoscopic ultrasound‐guided tissue acquisition for biliary lesions. Journal of Hepato-Biliary-Pancreatic Sciences. https://doi.org/10.1002/jhbp.12143
Vancouver
Agarie D, Hijioka S, Nagashio Y, Yamashige D, Okamoto K, Yagi S, et al. Diagnostic yields and clinical impact of endoscopic ultrasound‐guided tissue acquisition for biliary lesions. Journal of Hepato-Biliary-Pancreatic Sciences. 2025. doi:10.1002/jhbp.12143
BibTeX
@article{Agarie2025,
author = {Agarie, Daiki and Hijioka, Susumu and Nagashio, Yoshikuni and Yamashige, Daiki and Okamoto, Kohei and Yagi, Shin and Fukuda, Soma and Harai, Shota and Yamamoto, Kazuko and Okusaka, Takuji},
title = {Diagnostic yields and clinical impact of endoscopic ultrasound‐guided tissue acquisition for biliary lesions},
journal = {Journal of Hepato-Biliary-Pancreatic Sciences},
year = {2025},
doi = {10.1002/jhbp.12143}
}
EUVIMED